Endocyte Enters Oversold Territory (ECYT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of Endocyte Inc ( ECYT) entered into oversold territory, hitting an RSI reading of 29.96, after changing hands as low as $5.505 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 55.5. A bullish investor could look at ECYT's 29.96 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ECYT shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Endocyte Inc 1 Year Performance Chart

Looking at the chart above, ECYT's low point in its 52 week range is $5.01 per share, with $9.35 as the 52 week high point — that compares with a last trade of $5.50.

More from Stocks

Chart: Buybacks in Semiconductor Stocks Help Sector Weather the Storm

Chart: Buybacks in Semiconductor Stocks Help Sector Weather the Storm

Dow Slips for Fifth Day in Seven, Led Lower by IBM, Home Depot

Dow Slips for Fifth Day in Seven, Led Lower by IBM, Home Depot

Jim Cramer Dives Into Cannabis and IBM Earnings

Jim Cramer Dives Into Cannabis and IBM Earnings

Chart of the Day: Applied Materials Selling Stops as Signs of Recovery Emerge

Chart of the Day: Applied Materials Selling Stops as Signs of Recovery Emerge

How a No Deal Brexit Would Impact U.K. Stocks

How a No Deal Brexit Would Impact U.K. Stocks